National Review
Ending the Epidemic of Public-Nuisance Litigation
The opioid crisis has spawned a rash of litigation, with thousands of pending state and federal cases threatening to penalize legitimate…
National Review
What’s Taking the FDA So Long on COVID Drug Molnupiravir?
On October 1, pharmaceutical companies Merck and Ridgeback Biotherapeutics announced that their investigational oral antiviral drug Molnupiravir reduced the risk of hospitalization or…
New York Post
Letter Confirms Wuhan Lab’s COVID-19 Leak was Funded by US Taxpayers
The origin of the SARS-CoV-2 virus that causes COVID-19 remains unclear, but recent revelations reinforce the likelihood that the true source was a lab…
City Journal
Mandating Trouble
Thanks to Mayor Bill de Blasio’s Covid-19 vaccine mandate for city workers, New York faces the prospect of slower ambulance- and fire-response times, fewer…
City Journal
The Evidence Mounts
The origin of the SARS-CoV-2 virus that causes Covid-19 remains unclear, but recent revelations reinforce the likelihood that the true source…
National Review
Innovators to the Rescue
Thirty years ago, I spoke at a conference on xenotransplantation — the transplantation of organs, cells, or tissues between species — at…